| HOME >> MEDICINE >> TECHNOLOGY |
$ 75,666,291$ 75,964,967Current liabilities:Accounts payable
$
2,016,058$
,755,472Accrued expenses
2,069,2221,527,352Short-term debt
2,641,2332,786,622Total current liabilities
6,726,5136,069,446Long-term liabilitiesOther long-term liabilities
46,32755,889Long-term debt
-1,019,735Total long-term liabilities
46,3271,075,624Stockholders' equity
68,893,45168,819,897Total Liabilities and Stockholder's Equity
$ 75,666,291$ 75,964,967Summary Statements Of Operations(unaudited)(unaudited)Three months endedTwelve months endedSeptember 30,September 30,2010200920102009Sales
$ 11,121,229$ 9,009,299$ 41,442,680$ 34,798,829Cost of sales
5,731,7164,706,57921,739,01417,973,314Gross profit
5,389,5134,302,72019,703,66616,825,515Gross profit %
48%48%48%48%Costs and expenses:Marketing and selling
3,068,2882,771,46011,868,73710,327,396Research and development
304,548272,0841,235,3671,241,095General and administrative
1,583,2461,432,6106,391,0036,006,906Total operating expenses
4,956,0824,476,15419,495,10717,575,397Income (loss) from operations
433,431(173,434)208,559(749,882)Other income (expense)Interest income
139,48741,705239,171283,195Interest expense
(60,414)(40,627)(177,401)(259,341)Other income1,200,442Net income (loss) before income taxes
512,504(172,356)270,329474,414Income tax expense
340,48556,899523,864365,742Net income (loss)
$
72,019$ (229,255)$
(253,535)$
8,672Earnings (loss) per common share - Basic
$
.01$
(0.02)$
(0.02)$
.01Earnings (loss) per common share - Diluted
$
.01$
(0.02)$
(0.02)$
.01Weighted Average Shares:
12,142,76412,091,85612,181,54912,045,313BasicWeighted Average Shares:
12,785,99612,091,85612,181,54912,639,853Diluted
'/>"/>
| SOURCE Rochester Medical Corporation Copyright©2010 PR Newswire. All rights reserved |